These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 1309632

  • 1. [Evaluation of chemotherapy of unresectable non-small cell lung cancer].
    Hirabayashi M, Tanaka Y, Yoshida H, Nakagawa M, Kawakami K, Mishima M, Kuno K.
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):55-60. PubMed ID: 1309632
    [Abstract] [Full Text] [Related]

  • 2. [Current results of chemotherapy in non-small cell lung cancer].
    Fukuoka M, Negoro S, Takada M, Matsui K, Takifuji N, Masuda N, Kawahara M, Furuse K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):203-9. PubMed ID: 2162439
    [Abstract] [Full Text] [Related]

  • 3. [Comparative study on quality of life between weekly and monthly chemotherapy with cisplatin, vindesine and mitomycin C in patients with non-small cell lung cancer].
    Ishihara Y, Ichiwata T, Kuramitsu K, Yoneda S, Yamamoto M, Takizawa T, Ogata T, Uchiyama T, Yoshida K.
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):1013-20. PubMed ID: 9644316
    [Abstract] [Full Text] [Related]

  • 4. Cisplatin, vindesine, mitomycin-C and 13-cis retinoic acid in the treatment of advanced non small cell lung cancer. A phase II pilot study.
    Recchia F, Sica G, De Filippis S, Rosselli M, Saggio G, Guerriero G, Pompili P, Rea S.
    Anticancer Res; 2000 Jun; 20(3B):1985-90. PubMed ID: 10928138
    [Abstract] [Full Text] [Related]

  • 5. [A randomized comparative study of 254-S plus vindesine (VDS) vs. cisplatin (CDDP) plus VDS in patients with advanced non-small cell lung cancer (NSCLC)].
    Furuse K, Fukuoka M, Asamoto H, Niitani H, Kimura I, Sakuma A, Yamaguchi Y.
    Gan To Kagaku Ryoho; 1992 Jul; 19(7):1019-26. PubMed ID: 1320846
    [Abstract] [Full Text] [Related]

  • 6. [Combination chemotherapy including cisplatinum, vindesine and mitomycin C for non-small cell lung cancer].
    Hayashi Y, Kato M, Matsuura T, Yamada Y, Adachi S, Ito G, Yamamoto K, Takeuchi T.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1455-60. PubMed ID: 2167632
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic factors affecting survival and response in patients with advanced non-small cell lung cancer treated with combination chemotherapy].
    Takifuji N, Fukuoka M, Negoro S, Takada M, Kusunoki Y, Matsui K, Masuda N, Ryu S, Sakai N, Kubota K.
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):429-34. PubMed ID: 2157364
    [Abstract] [Full Text] [Related]

  • 8. [Activity of toremifene plus mitomycin, vindesin and cisplatin regimen in unresectable non-small cell lung cancer].
    Zhou CC, Zhang J, Zheng D, Lu MJ, Lu B, Xu JF.
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Aug; 27(8):546-8. PubMed ID: 15388005
    [Abstract] [Full Text] [Related]

  • 9. [Comparative study on vindesine plus cisplatin treatment of advanced non-small cell lung cancer--three divided doses (35 mg/m2, day 1, 8, 15) and single dose (80 mg/m2, day 1) of cisplatin. Chiba Lung Cancer Study Group].
    Nagao K, Fujisawa T, Miyamoto T, Kikuchi N, Takizawa H, Satoh K, Yamagishi F, Yamaguchi T, Mizutani F, Nakano K.
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):425-30. PubMed ID: 1848421
    [Abstract] [Full Text] [Related]

  • 10. [Prospective randomized study of HMVP, MVP, and HVP regimens in treatment of advanced non-small cell lung cancer].
    Gao JF, Li CS, Zhang BC, Du GZ, Zhang XH, Wang J, Zhu YZ, Ou WL, Yang B.
    Ai Zheng; 2004 Apr; 23(4):435-8. PubMed ID: 15087034
    [Abstract] [Full Text] [Related]

  • 11. [A randomized controlled study of post-operative adjuvant therapy in non-small cell lung cancer].
    Fukushima M, Tsushima T, Ito H, Fukuda Y, Maruyama A, Fujita H, Yagihashi N, Tsuge T, Ishioka T, Kudo T, Kishibe S, Sato T, Machida S, Kogawa R, Takashima K, Koie H, Fujita K.
    Gan To Kagaku Ryoho; 1996 Feb; 23(3):303-9. PubMed ID: 8712823
    [Abstract] [Full Text] [Related]

  • 12. Induction chemotherapy in non small cell lung cancer stage IIIa-b and IV and second-line treatment.
    Stathopoulos GP, Dafni UG, Malamos NA, Rigatos S, Kouvatseas G, Moschopoulos N.
    Anticancer Res; 1999 Feb; 19(4C):3543-8. PubMed ID: 10629650
    [Abstract] [Full Text] [Related]

  • 13. [Radiotherapy combined with cis-diammine-dichloro platinum (II) plus vindesine in the treatment of non-small cell lung cancer: a comparison with treatment by radiation alone].
    Koga K, Minoda S, Murai N, Nishikawa K.
    Gan No Rinsho; 1990 Apr; 36(5):593-7. PubMed ID: 2157906
    [Abstract] [Full Text] [Related]

  • 14. [Mitomycin, vindesine and cisplatin combination therapy in the treatment of advanced non-small cell lung cancer: a report of 108 cases].
    Zhang X, Sun Y, Feng F.
    Zhonghua Zhong Liu Za Zhi; 1999 May; 21(3):220-3. PubMed ID: 11776842
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of treatment efficacy of the second and the third generations of chemoradiotherapy regimens containing platinum on advanced non-small cell lung cancer].
    Wang YM, Guo LJ, Li LS, Li P, Zheng J, Li L.
    Ai Zheng; 2005 Dec; 24(12):1514-7. PubMed ID: 16351804
    [Abstract] [Full Text] [Related]

  • 16. [Combination chemotherapy with Taxol and cisplatin for 57 patients with non-small cell lung cancer by intraartery and intravenous infusion].
    Zhao Y, Wang SM, Zhang J.
    Ai Zheng; 2002 Dec; 21(12):1365-7. PubMed ID: 12520750
    [Abstract] [Full Text] [Related]

  • 17. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M, Study Group of Adjuvant Chemotherapy for Lung Cancer (Chubu, Japan).
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [Abstract] [Full Text] [Related]

  • 18. [A randomized trial comparing vindesine plus cisplatin with mitomycin C, vindesine plus cisplatin in patients with advanced non-small cell lung cancer].
    Fujii M, Kiura K, Okabe K, Toki H, Kimura M.
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2676-81. PubMed ID: 2820312
    [Abstract] [Full Text] [Related]

  • 19. Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale).
    Gebbia V, Galetta D, Lorusso V, Caruso M, Verderame F, Pezzella G, Borsellino N, Durini E, Valenza R, Agostara B, Colucci G, Gruppo Oncologico Italia Meridionale.
    Lung Cancer; 2008 Sep; 61(3):369-77. PubMed ID: 18308419
    [Abstract] [Full Text] [Related]

  • 20. [Phase II studies of a single agent and a cis-platinum-based two-drug combination in patients with non-small cell lung cancer].
    Yamamoto M, Furuse K, Fukuoka M, Kawahara M, Arai R, Kodama N, Takada M, Negoro S, Matsui K, Ryu S.
    Gan To Kagaku Ryoho; 1988 Mar; 15(3):487-92. PubMed ID: 2831821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.